• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Mary Cooley Ph.D. R.N.

Instructor, Department of Psychiatry, Harvard Medical School

Nurse Scientist, Nursing and Patient Care, Dana-Farber Cancer Institute

Contact Info

Mary Cooley
Dana-Farber Cancer Institute
44 Binney Street
Boston, MA, 02115
Mailstop: G220
Phone: 6176324653
Fax: 6176325636
mary_cooley@dfci.harvard.edu

Assistant

Romelia Salazar
Phone: 6176321925
Fax: 6176325636
rsalazar@partners.org

DF/HCC Program Affiliation

Member, Lung Cancer Program
Member, Cancer Nursing Research Program
Member, Palliative Care Program

Research Abstract

Major research interests are tobacco control, smoking cessation interventions, symptom management, and quality of life during treatment for cancer with a particular emphasis on lung cancer.

Publications

  • Cooley ME, Sarna L, Brown JK, Williams RD, Chernecky C, Padilla G, Danao LL, Elashoff D. Tobacco use in women with lung cancer. Ann Behav Med 2007 May-Jun; 33(3):242-50
    PMID: 17600451
  • Cooley ME, Sarna L, Brown JK, Williams RD, Chernecky C, Padilla G, Danao LL. Challenges of recruitment and retention in multisite clinical research. Cancer Nurs 2003 Oct; 26(5):376-84; quiz 385-6
    PMID: 14710799
  • Sarna L, Cooley ME, Danao L. The global epidemic of tobacco and cancer. Semin Oncol Nurs 2003 Nov; 19(4):233-43
    PMID: 14702857
  • Cooley ME, Short TH, Moriarty HJ. Symptom prevalence, distress, and change over time in adults receiving treatment for lung cancer. Psychooncology 2003 Oct-Nov; 12(7):694-708
    PMID: 14502594
  • Cooley ME, Short TH, Moriarty HJ. Patterns of symptom distress in adults receiving treatment for lung cancer. J Palliat Care 2002 Fall; 18(3):150-9
    PMID: 12418365
  • Cooley ME, Kaiser LR, Abrahm JL, Giarelli E. The silent epidemic: tobacco and the evolution of lung cancer and its treatment. Cancer Invest 2001; 19(7):739-51
    PMID: 11577815